Genmab — Januar 2020
-
GENMAB/SYDBANK: DARZALEX-SALGET RUNDER 4 MIA. DOLLAR I 2020.
-
- Vi estimerer et markedssalg for Darzalex på 4144 mio. dollar i 2020
-
on teprotumumab - i read 'the company explained that the full course requires 23 vials, setting the cost at $343,000 wholesale acquisition cost' and in their presentation 'Expected average net realized price: ~$200,000' https://endpts.com/fda-hands-off-its-latest-whirlwind-drug-ok-as-horizon-hustles-would-be-blockbuster-to-the-market/
-
@AaBforever that is very close to what Danske had in october, 4146...
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind